Twist Bioscience Corporation· TWST
🇺🇸 US · MidBroad USNASDAQ
- Price
- $99.45
- Day
- -1.60%
- Mkt Cap
- $6.19B
- 52W Range
- $23.30 – $106.58
- Volume
- 1.24M
- Beta
- 2.16
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Twist Bioscience Corporation (Nasdaq: TWST) (âTwistâ), a mid-cap growth and value biotech company, today announced the pricing of an upsized underwritten pu
Read full article
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (Nasdaq: TWST) (“Twist”), a mid-cap growth and value biotech company, today announced the commencement of an underwritten public offering of $250.0 million of shares of its common stock. In addition, Twist intends to grant the underwriters a 30-day option to purchase up to an additional $37.5 million of shares of its common stock. All of the shares of common stock to be sold in the proposed offering are being offered by.
Read full article
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (Nasdaq: TWST) (“Twist”), a mid-cap growth and value biotech company, today announced the pricing of an upsized underwritten public offering of 3,125,000 shares of its common stock at a price to the public of $96.00 per share. All of the shares of common stock to be sold in the public offering are to be sold by Twist. The gross proceeds to Twist from the offering, before deducting the underwriting discounts and commissio.
Read full article
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a mid-cap growth and value biotech company, today announced that a total of 44,434 restricted stock units (“RSUs”) will be granted to 24 recently hired individuals, in each case as an inducement material to their acceptance of employment with Twist. The employment inducement awards will be granted under Twist's Amended and Res.
Read full article
First Trust Advisors LP acquired a new position in Twist Bioscience Corporation (NASDAQ: TWST) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 104,650 shares of the company's stock, valued at approximately $4,973,000. First Trust Advisors LP owned
Read full article
Twist Bioscience Corporation (TWST) Q3 2026 Earnings Call Transcript
Read full article
Twist Bioscience Corporation (NASDAQ:TWST) stock is up on Monday as the company reported its fiscal 2026 third-quarter financial results and raised fiscal 2026 guidance.
Read full article
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the third quarter fiscal 2026 ended June 30, 2026. Visit the Events and Presentations page of the Investor Relations section under the “Company” tab at www.twistbioscience.com to view the detailed fiscal third quarter 2026 earnings report and the investor presentation, or click https://investors.twist.
Read full article
[url="]Twist Bioscience Corporation[/url] (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights
Read full article
Twist Bioscience NASDAQ: TWST reported fiscal 2026 third-quarter revenue of $118.4 million, up 23% from a year earlier, marking its 14th consecutive quarter of growth. The company raised its full-year revenue outlook and said it remains on track to reach adjusted EBITDA breakeven in the fiscal fourth quarter.
Read full article
Twist Bioscience (TWST) came out with a quarterly loss of $0.56 per share versus the Zacks Consensus Estimate of a loss of $0.5. This compares to a loss of $0.47 per share a year ago.
Read full article
Allspring Global Investments Holdings LLC purchased a new position in shares of Twist Bioscience Corporation (NASDAQ: TWST) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 455,446 shares of the company's stock, valued at approximately $22,563,000. Allspring Global Investments Holdings LLC owned approximately 0.74%
Read full article